SE338987B - - Google Patents

Info

Publication number
SE338987B
SE338987B SE03078/68A SE307868A SE338987B SE 338987 B SE338987 B SE 338987B SE 03078/68 A SE03078/68 A SE 03078/68A SE 307868 A SE307868 A SE 307868A SE 338987 B SE338987 B SE 338987B
Authority
SE
Sweden
Application number
SE03078/68A
Inventor
H Lessenich
G Haertfelder
H Ruschig
K Schmitt
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of SE338987B publication Critical patent/SE338987B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
SE03078/68A 1967-03-10 1968-03-08 SE338987B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEF0051784 1967-03-10
DEF0054258 1967-12-08

Publications (1)

Publication Number Publication Date
SE338987B true SE338987B (de) 1971-09-27

Family

ID=25977598

Family Applications (1)

Application Number Title Priority Date Filing Date
SE03078/68A SE338987B (de) 1967-03-10 1968-03-08

Country Status (11)

Country Link
US (1) US3551493A (de)
AT (7) AT304469B (de)
BE (1) BE711997A (de)
CH (2) CH525184A (de)
DE (1) DE1668055B2 (de)
DK (1) DK133095C (de)
FR (2) FR1575615A (de)
GB (1) GB1215751A (de)
NL (1) NL154204B (de)
NO (1) NO125723B (de)
SE (1) SE338987B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758303A (fr) * 1969-11-03 1971-04-30 Roussel Uclaf Nouveaux derives du 1-amino 3-phenoxy 2-propanol et procede de preparation
US4360464A (en) * 1969-11-28 1982-11-23 Teikoku Hormone Mfg. Co. Ltd. Process for production of 1-aryloxy-aminopropane derivatives
US4018824A (en) * 1969-11-28 1977-04-19 Teikoku Hormone Mfg. Co., Ltd. 1-Aryloxy-3-aminopropane derivatives
GB1458392A (en) * 1973-11-09 1976-12-15 Ici Ltd Optically-active 1-aryloxy-2,3-epoxypropane derivatives
FR2361106A2 (fr) * 1976-08-10 1978-03-10 Mar Pha Etu Et Expl De Marques Nouvelles terpeno-phenoxy-alkylamines
DE3012012A1 (de) * 1980-03-28 1981-10-08 Beiersdorf Ag, 2000 Hamburg Substituierte 3-aryl-2-cycloalken-1-one und verfahren zu ihrer herstellung
RU1795965C (ru) * 1988-06-03 1993-02-15 Эли Лилли Энд Компани Способ получени производных пропаноламина или их фармакологически приемлемых кислотно-аддитивных солей.
US5013761A (en) * 1988-06-03 1991-05-07 Eli Lilly And Company Serotonin antagonists
US5340838A (en) * 1990-05-04 1994-08-23 Eli Lilly And Company Method of inhibiting gastric acid secretion with 2-phenylcyclopropylamines
US5096908A (en) * 1990-05-04 1992-03-17 Eli Lilly And Company Method of inhibiting gastric acid secretion
US5258379A (en) * 1990-05-04 1993-11-02 Eli Lilly And Company Method of inhibiting gastric acid secretion with n-arylpiperazines
CA2134038C (en) * 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
EP0714663A3 (de) 1994-11-28 1997-01-15 Lilly Co Eli Potenzierung von Wirkstoffresponz durch Serotonin 1A Rezeptor Antagonisten
DE69607904T2 (de) * 1995-08-16 2000-10-05 Lilly Co Eli Potenzierung von Serotonin-Wirkstoffresponz
US7034059B2 (en) * 2001-07-02 2006-04-25 Sepracor Inc. Methods of using norfluoxetine
ES2362998T3 (es) 2002-08-19 2011-07-18 Pfizer Inc. Terapia de combinación para enfermedades hiperproliferativas.
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
JP5498168B2 (ja) 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー アテローム性動脈硬化および循環器疾患の治療のためのcetp阻害剤としてのn−((3−ベンジル)−2,2−(ビス−フェニル)−プロパン−1−アミン誘導体
WO2008112287A1 (en) 2007-03-12 2008-09-18 Nektar Therapeutics Oligomer-beta blocker conjugates
EP2986599A1 (de) 2013-04-17 2016-02-24 Pfizer Inc. N-piperidin-3-ylbenzamid-derivate zur behandlung von herz-kreislauf-erkrankungen
EP2959904A1 (de) 2014-06-27 2015-12-30 Institut De Recerca Contra La Leucemia Josep Carreras Verfahren zur Behandlung, Diagnose und Prognose einer hämatologischen Malignität
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CR20210441A (es) 2019-01-18 2022-03-11 Astrazeneca Ab Inhibidores de la pcsk9 y métodos de uso de los mismos

Also Published As

Publication number Publication date
AT304470B (de) 1973-01-10
FR1575615A (de) 1969-07-25
AT289066B (de) 1971-04-13
AT291971B (de) 1971-08-10
US3551493A (en) 1970-12-29
AT291973B (de) 1971-08-10
AT304469B (de) 1973-01-10
DE1618386A1 (de) 1971-03-25
BE711997A (de) 1968-09-11
CH525184A (de) 1972-07-15
CH508584A (de) 1971-06-15
DE1668055A1 (de) 1971-07-15
AT291972B (de) 1971-08-10
DK133095C (da) 1976-08-23
DE1668055B2 (de) 1973-09-06
NL154204B (nl) 1977-08-15
DE1618386B2 (de) 1975-09-18
FR8070M (de) 1970-07-15
NO125723B (de) 1972-10-23
GB1215751A (en) 1970-12-16
DK133095B (da) 1976-03-22
AT304473B (de) 1973-01-10
DE1668055C3 (de) 1974-05-02
NL6803035A (de) 1968-09-11

Similar Documents

Publication Publication Date Title
AU425114B2 (de)
AT298283B (de)
AU416737B2 (de)
AU342066A (de)
AU2277767A (de)
AU2256867A (de)
AU2454867A (de)
AU610966A (de)
AU3189468A (de)
AU3151267A (de)
AU1273466A (de)
AU2116667A (de)
AU2977667A (de)
AU2528767A (de)
BE711997A (de)
AU34866A (de)
AU23366A (de)
AU2406369A (de)
BE710348A (de)
BE483855A (de)
BE710301A (de)
BE692492A (de)
BE509738A (de)
BE692409A (de)
AU3054676A (de)